Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 33

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

COMMD7 Regulates NF-κB Signaling Pathway in Hepatocellular Carcinoma Stem-like Cells

Zheng, Lu, You, Nan, Huang, Xiaobing, Gu, Huiying, Wu, Ke, Mi, Na, Li, Jing·2019·Molecular Therapy Oncolytics

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.omto.2018.12.006

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 39

  1. Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int. J. Cancer, 136, E359, 10.1002/ijc.29210 · DOI · Paper page
  2. Mittal, 2013, Epidemiology of hepatocellular carcinoma: consider the population, J. Clin. Gastroenterol., 47, S2, 10.1097/MCG.0b013e3182872f29 · DOI · Paper page
  3. Mir, 2017, Epithelial-to-mesenchymal transition: a mediator of sorafenib resistance in advanced hepatocellular carcinoma, Curr. Cancer Drug Targets, 17, 698, 10.2174/1568009617666170427104356 · DOI
  4. Llovet, 2014, Liver cancer: time to evolve trial design after everolimus failure, Nat. Rev. Clin. Oncol., 11, 506, 10.1038/nrclinonc.2014.136 · DOI
  5. Jiang, 2017, miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma, J. Exp. Clin. Cancer Res, 36, 99, 10.1186/s13046-017-0568-3 · DOI
  6. El-Serag, 2007, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis, Gastroenterology, 132, 2557, 10.1053/j.gastro.2007.04.061 · DOI · Paper page
  7. Visvader, 2008, Cancer stem cells in solid tumours: accumulating evidence and unresolved questions, Nat. Rev. Cancer, 8, 755, 10.1038/nrc2499 · DOI · Paper page
  8. Clarke, 2006, Cancer stem cells—perspectives on current status and future directions: AACR Workshop on cancer stem cells, Cancer Res., 66, 9339, 10.1158/0008-5472.CAN-06-3126 · DOI · Paper page
  9. Dean, 2005, Tumour stem cells and drug resistance, Nat. Rev. Cancer, 5, 275, 10.1038/nrc1590 · DOI · Paper page
  10. Yang, 2008, Significance of CD90+ cancer stem cells in human liver cancer, Cancer Cell, 13, 153, 10.1016/j.ccr.2008.01.013 · DOI · Paper page
  11. Xu, 2017, Growth differentiation factor 15 induces growth and metastasis of human liver cancer stem-like cells via AKT/GSK-3β/β-catenin signaling, Oncotarget, 8, 16972, 10.18632/oncotarget.15216 · DOI
  12. Song, 2013, Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review), Oncol. Rep., 29, 3, 10.3892/or.2012.2082 · DOI
  13. Huo, 2017, Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells, Mol. Cancer, 16, 165, 10.1186/s12943-017-0734-4 · DOI · Paper page
  14. Hayden, 2012, NF-κB, the first quarter-century: remarkable progress and outstanding questions, Genes Dev., 26, 203, 10.1101/gad.183434.111 · DOI · Paper page
  15. Hassanzadeh, 2011, Colorectal cancer and NF-κB signaling pathway, Gastroenterol. Hepatol. Bed Bench, 4, 127
  16. Wang, 2014, Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: involvement of NF-κB signaling pathway, Biochem. Pharmacol., 88, 322, 10.1016/j.bcp.2014.01.041 · DOI
  17. Lin, 2010, The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy, Expert Opin. Ther. Targets, 14, 45, 10.1517/14728220903431069 · DOI · Paper page
  18. Bartuzi, 2013, Tuning NF-κB activity: a touch of COMMD proteins, Biochim. Biophys. Acta, 1832, 2315, 10.1016/j.bbadis.2013.09.014 · DOI · Paper page
  19. Burstein, 2005, COMMD proteins, a novel family of structural and functional homologs of MURR1, J. Biol. Chem., 280, 22222, 10.1074/jbc.M501928200 · DOI · Paper page
  20. Geng, 2009, Phosphorylation of NF-kappaB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination, EMBO Rep., 10, 381, 10.1038/embor.2009.10 · DOI
  21. Zoubeidi, 2010, Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells, Mol. Cancer Res., 8, 119, 10.1158/1541-7786.MCR-09-0277 · DOI
  22. Fernández Massó, 2013, The antitumor peptide CIGB-552 increases COMMD1 and inhibits growth of human lung cancer cells, J. Amino Acids, 2013, 251398
  23. You, 2017, COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma, Mol. Carcinog., 56, 607, 10.1002/mc.22520 · DOI
  24. Zheng, 2012, ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth, PLoS ONE, 7, e45412, 10.1371/journal.pone.0045412 · DOI
  25. Zheng, 2016, COMMD7 is correlated with a novel NF-κB positive feedback loop in hepatocellular carcinoma, Oncotarget, 7, 32774, 10.18632/oncotarget.9047 · DOI
  26. Esposito, 2016, COMMD7 as a novel NEMO interacting protein involved in the termination of NF-κB signaling, J. Cell. Physiol., 231, 152, 10.1002/jcp.25066 · DOI · Paper page
  27. Mabb, 2006, PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress, Nat. Cell Biol., 8, 986, 10.1038/ncb1458 · DOI · Paper page
  28. You, 2017, COMMD7 promotes hepatocellular carcinoma through regulating CXCL10, Biomed. Pharmacother., 88, 653, 10.1016/j.biopha.2017.01.046 · doi:10.1016/j.biopha.2017.01.046
  29. Meng, 2010, Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer, Cancer Biol. Ther., 9, 295, 10.4161/cbt.9.4.10666 · DOI · Paper page
  30. Jeter, 2009, Functional evidence that the self-renewal gene NANOG regulates human tumor development, Stem Cells, 27, 993, 10.1002/stem.29 · DOI · Paper page
  31. Tang, 2008, Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling, Proc. Natl. Acad. Sci. USA, 105, 2445, 10.1073/pnas.0705395105 · DOI · Paper page
  32. Oliva, 2010, The identification of stem cells in human liver diseases and hepatocellular carcinoma, Exp. Mol. Pathol., 88, 331, 10.1016/j.yexmp.2010.01.003 · DOI
  33. Tanaka, 2006, Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer, J. Pathol., 208, 662, 10.1002/path.1928 · DOI · Paper page
  34. Mizuguchi, 1998, Alteration of expression of liver-enriched transcription factors in the transition between growth and differentiation of primary cultured rat hepatocytes, J. Cell. Physiol., 174, 273, 10.1002/(SICI)1097-4652(199803)174:3<273::AID-JCP1>3.0.CO;2-L · DOI
  35. Saha, 2014, Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer, Nature, 513, 110, 10.1038/nature13441 · DOI · Paper page
  36. Walesky, 2015, Role of hepatocyte nuclear factor 4α (HNF4α) in cell proliferation and cancer, Gene Expr., 16, 101, 10.3727/105221615X14181438356292 · DOI
  37. Lee, 2014, β-Catenin signaling in hepatocellular cancer: implications in inflammation, fibrosis, and proliferation, Cancer Lett., 343, 90, 10.1016/j.canlet.2013.09.020 · DOI
  38. Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262 · DOI · Paper page
  39. Kanehisa, 2000, KEGG: kyoto encyclopedia of genes and genomes, Nucleic Acids Res., 28, 27, 10.1093/nar/28.1.27 · DOI · Paper page

Cited by

See all 33

Metadata

Authors
Zheng, L., You, N., Huang, X., Gu, H., Wu, K., Mi, N., & Li, J.
Venue
Molecular Therapy Oncolytics
Publisher
Elsevier BV
Published
2019-03
Volume
12
Pages
112-123
ISSN
2372-7705
Cited by
33
References
1
Language
en
Licence
Funders
National Natural Science Foundation of China (81372561, 81672902)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: COMMD7 Regulates NF-κB Signaling Pathway in Hepatocellular Carcinoma Stem-like Cells. https://app.cochat.ai/papers/10.1016/j.omto.2018.12.006
The paper
Zheng, L., You, N., Huang, X., Gu, H., Wu, K., Mi, N., & Li, J. (2019). COMMD7 Regulates NF-κB Signaling Pathway in Hepatocellular Carcinoma Stem-like Cells. Molecular Therapy Oncolytics. https://doi.org/10.1016/j.omto.2018.12.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.